C. Aul

1.1k total citations
37 papers, 722 citations indexed

About

C. Aul is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, C. Aul has authored 37 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 9 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in C. Aul's work include Acute Myeloid Leukemia Research (16 papers), Multiple Myeloma Research and Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). C. Aul is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Multiple Myeloma Research and Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). C. Aul collaborates with scholars based in Germany, United States and France. C. Aul's co-authors include Norbert Gattermann, Wolfgang Schneider, Ulrich Germing, A. Heyll, G. Derigs, Volker Runde, D. Söhngen, W Schneider, Aristoteles Giagounidis and Matthias Leschke and has published in prestigious journals such as Blood, Leukemia and Haematologica.

In The Last Decade

C. Aul

33 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Aul Germany 15 519 250 181 109 87 37 722
G Broccia Italy 16 695 1.3× 243 1.0× 172 1.0× 51 0.5× 49 0.6× 39 931
Knud Bendix‐Hansen Denmark 13 389 0.7× 174 0.7× 89 0.5× 123 1.1× 62 0.7× 28 612
Jean Pierre Jouet France 13 731 1.4× 356 1.4× 162 0.9× 60 0.6× 51 0.6× 24 904
Gita Massey United States 14 678 1.3× 162 0.6× 221 1.2× 58 0.5× 24 0.3× 40 1.1k
Tatsumi Uchida Japan 13 298 0.6× 158 0.6× 88 0.5× 63 0.6× 37 0.4× 59 528
John E. Kurnick United States 12 314 0.6× 171 0.7× 63 0.3× 55 0.5× 45 0.5× 21 633
Germán A. Gómez United States 16 402 0.8× 380 1.5× 119 0.7× 158 1.4× 27 0.3× 59 903
Jane Mercieca United Kingdom 10 467 0.9× 322 1.3× 59 0.3× 45 0.4× 50 0.6× 14 835
P. Y. Le Prise France 10 285 0.5× 112 0.4× 137 0.8× 47 0.4× 28 0.3× 19 495
L. Clifford McKee United States 10 222 0.4× 152 0.6× 72 0.4× 59 0.5× 40 0.5× 15 482

Countries citing papers authored by C. Aul

Since Specialization
Citations

This map shows the geographic impact of C. Aul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Aul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Aul more than expected).

Fields of papers citing papers by C. Aul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Aul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Aul. The network helps show where C. Aul may publish in the future.

Co-authorship network of co-authors of C. Aul

This figure shows the co-authorship network connecting the top 25 collaborators of C. Aul. A scholar is included among the top collaborators of C. Aul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Aul. C. Aul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schuler, Esther, Friederike Frank, Barbara Hildebrandt, et al.. (2017). Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML. Leukemia Research. 65. 1–4. 16 indexed citations
2.
Aul, C., Ulrich Germing, Norbert Gattermann, D. Söhngen, & A. Heyll. (2008). Prognostische Bedeutung der Serum-Thymidinkinase beim myelodysplastischen Syndrom. DMW - Deutsche Medizinische Wochenschrift. 121(37). 1113–1118. 1 indexed citations
3.
Thomas, Mathew, et al.. (2008). Embolisierende Aortenklappenendokarditis als Differentialdiagnose der thrombotisch-thrombozytopenischen Purpura. DMW - Deutsche Medizinische Wochenschrift. 117(19). 738–742.
4.
Heyll, A., et al.. (2008). Behandlung des multiplen Myeloms: Theoretische Grundlagen und klinisches Vorgehen. DMW - Deutsche Medizinische Wochenschrift. 118(26). 986–994.
5.
Germing, Ulrich, Corinna Strupp, A. Kuendgen, et al.. (2007). Chronic myelomonocytic leukemia in the light of the WHO proposals. Haematologica. 92(7). 974–977. 44 indexed citations
6.
Hehlmann, R., Ute Berger, C. Aul, et al.. (2004). Das Kompetenznetzwerk „Akute und chronische Leukämien”. DMW - Deutsche Medizinische Wochenschrift. 129(49). 2660–2665. 1 indexed citations
7.
Hopfinger, Georg, Elisabeth Koller, Barbara Schmitt, et al.. (2003). T-PLL-1 protocol of the German CLL study group (GCLLSG) - a prospective phase II trial of fludarabine phosphate, mitoxantrone and cyclophosphamide (FMC) followed by alemtuzumab consolidation as first-line treatment in T-PLL.. mediaTUM (Technical University of Munich). 6 indexed citations
8.
Aul, C., Aristoteles Giagounidis, Ulrich Germing, & Arnold Ganser. (2002). Evaluating the prognosis of patients with myelodysplastic syndromes. Annals of Hematology. 81(9). 485–497. 26 indexed citations
9.
10.
Heyll, A., et al.. (2000). Aktuelle Therapiekonzepte bei Patienten mit multiplem Myelom. DMW - Deutsche Medizinische Wochenschrift. 125(40). 1201–1209. 1 indexed citations
11.
Heyll, A., D. Söhngen, Guido Kobbe, et al.. (1997). Idarubicin, melphalan and cyclophosphamide: an intensified high-dose regimen for the treatment of myeloma patients.. PubMed. 11 Suppl 5. S32–4. 7 indexed citations
12.
Verbeek, Walter, Bernhard Wörmann, P. Koch, et al.. (1997). S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromes. Annals of Hematology. 74(5). 205–208. 16 indexed citations
13.
Südhoff, T, et al.. (1996). Levels of circulating endothelial adhesion molecules (sE-selectin and sVCAM-1) in adult patients with acute leukemia.. PubMed. 10(4). 682–6. 20 indexed citations
14.
Heyll, A., E. M. Schneider, Barbara Hildebrandt, et al.. (1995). Acute leukemia coexpressing myeloid, B- and T-lineage associated markers: multiparameter analysis of criteria defining lineage commitment and maturational stage in a case of undifferentiated leukemia.. PubMed. 9(2). 260–4. 4 indexed citations
15.
Aul, C., Volker Runde, & Norbert Gattermann. (1993). All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot study. Blood. 82(10). 2967–2974. 44 indexed citations
16.
Jaeger, M., C. Aul, D. Söhngen, Ulrich Germing, & Wolfgang Schneider. (1992). [Secondary hemochromatosis in polytransfused patients with myelodysplastic syndromes].. PubMed. 30. 464–8. 28 indexed citations
17.
Aul, C., Norbert Gattermann, A. Heyll, et al.. (1992). Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.. PubMed. 6(1). 52–9. 210 indexed citations
18.
Arning, M., et al.. (1991). Influence of Infusion Time on the Acute Toxicity of Amphotericin B: Results of a Randomized Double-Blind Study. Recent results in cancer research. 121. 347–352. 13 indexed citations
19.
Aul, C. & Wolfgang Schneider. (1990). Treatment of Advanced Myelodysplastic Syndromes: Trend Toward More Aggressive Chemotherapy?. Hämatologie und Bluttransfusion. 33. 382–386. 9 indexed citations
20.
Horstkotte, Dieter, C. Aul, L Seipel, et al.. (1983). [Effect of valve type and valve function on chronic intravascular hemolysis after alloprosthetic mitral and aortic valve replacement].. PubMed. 72(2). 119–31. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Broccia Breakdown of academic impact, for papers by Knud Bendix‐Hansen Breakdown of academic impact, for papers by Jean Pierre Jouet Breakdown of academic impact, for papers by Gita Massey Breakdown of academic impact, for papers by Tatsumi Uchida Breakdown of academic impact, for papers by John E. Kurnick Breakdown of academic impact, for papers by Germán A. Gómez Breakdown of academic impact, for papers by Jane Mercieca Breakdown of academic impact, for papers by P. Y. Le Prise Breakdown of academic impact, for papers by L. Clifford McKee
Rankless by CCL
2026